KDIGO急性肾损伤1期内部结局差异显著
该回顾性队列研究纳入5家医院2012至2014年81651例住院患者,将KDIGO急性肾损伤1期按血肌酐标准细分为1a期(48小时内绝对值升高0.3 mg/dl)和1b期(7天内相对升高50%)。结果显示1a期与1b期在住院时长和死亡风险上存在临床意义显著差异,提示改良的四期分类可能提供额外预后信息。
要点
- KDIGO 1期AKI可细分为1a期和1b期,两者预后差异显著
- 1b期患者住院时长和死亡风险均高于1a期
- 改良四期分类可能为AKI预后评估提供更多信息
核心结论
- KDIGO 1期AKI内部存在结局差异,1a期与1b期在住院时长和死亡率上有临床意义和统计学显著差异。
- 改良的四期KDIGO AKI分类可能提供额外预后信息。
研究设计与样本
- 回顾性队列研究,筛查5家医院2012至2014年所有住院患者,最终纳入81651例住院。
- AKI 1a期定义为48小时内血清肌酐绝对值升高0.3 mg/dl,1b期定义为7天内血清肌酐相对升高50%。
主要发现
- 院内AKI发生率:1a期7.5%,1b期4.9%,2期1.5%,3期0.9%。
- 首次AKI发生后住院时长:1a期3.9天,1b期6.2天,2期8.8天,3期12.0天。
- 与无AKI患者相比,院内死亡风险随AKI分期递增:1a期OR 4.3,1b期OR 10.9,2期OR 40.6,3期OR 60.0。
关键数值与推荐
- AKI 1a期:48小时内血清肌酐绝对值升高0.3 mg/dl。
- AKI 1b期:7天内血清肌酐相对升高50%。
临床怎么用
- 临床可考虑将KDIGO 1期AKI进一步细分为1a和1b期以更精细评估预后。
- 对1b期患者应警惕更高的死亡风险和更长的住院时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline classifies acute kidney injury (AKI) into 3 stages defined by serum creatinine elevation or urine output decline. We evaluated the potential impact of further categorizing AKI stage 1 into two stages based on serum creatinine criteria, with a focus on how the resulting 4-stage classification would affect the association of AKI stages with clinical outcomes. We defined AKI stage 1a as an absolute increase in serum creatinine of 0.3 mg/dl within 48 hours and stage 1b as a 50% relative increase in serum creatinine within 7 days. We screened all admissions to 5 hospitals from 2012 to 2014 using standardized inclusion and exclusion criteria and included 81,651 admissions in this retrospective cohort study. The incidence of in-hospital AKI was 7.5% for stage 1a, 4.9% for stage 1b, 1.5% for stage 2, and 0.9% for stage 3. Length of stay following the first incidence of AKI was 3.9 days for stage 1a, 6.2 days for stage 1b, 8.8 days for stage 2, and 12.0 days for stage 3. Compared to patients with no AKI, the odds of in-hospital mortality were progressively higher for patients with higher AKI stages (odds ratio 4.3 for patients with stage 1a, 10.9 for stage 1b, 40.6 for stage 2, and 60.0 for stage 3 AKI). Patients with AKI stages 1a and 1b experienced clinically meaningful and statistically significant differences in length of stay and mortality. This study suggests that a modified 4-stage version of the KDIGO AKI classification may provide additional prognostic information.
引用
- Sparrow HG, Swan JT, Moore LW, et al. Disparate outcomes observed within Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury stage 1. Kidney Int. 2019. PMID: 30819553. doi:10.1016/j.kint.2018.11.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。